Home›Companies›Biotech & Pharma›Excellos

Excellos, Inc.

Updated Oct 27, 2026·Latest SEC filing Aug 16, 2023·Suggest an edit

About Excellos

Excellos is a private company based in San Diego, California, incorporated in 2020 in Delaware. It has reported $20,000,000 raised in two offerings on Form D since November 2021. Its chief executive is Deval Lashkari, Ph.D..

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 1, 2023Aug 16, 2023$4,999,999of $7.0M target1$4.9MEquityRule 506(c)Form D ↗
Nov 5, 2021Nov 24, 2021$15,000,001fully sold1$15.0MEquityRule 506(b)Form D ↗
Total, two offerings$20,000,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Excellos's Form D filed Aug 16, 2023.

DD
Deval Lashkari, Ph.D.
Chief Executive Officer and director
DD
David Wellis, Ph.D.
Chief Executive Officer and director
RF
Robert Finzi
Director

Earlier filings also listed Paul Grossman (director, last listed Nov 2021), Deval Lashkari (director, last listed Nov 2021) and Alex Herzik (director, last listed Nov 2021).

Sources

  1. SECEXCELLOS, Inc filing history